Table 3.
Different application areas and mechanisms of action of ZnO-NPs
| Application Area | Mechanism of Action | Therapeutic Effect | Research Progress | Ref |
|---|---|---|---|---|
| Chemotherapy sensitizer | Inhibition of P-gp expression improved cell membrane permeability | Increased intracellular drug accumulation, enhanced chemotherapy efficiency | Further research is needed to determine effective concentrations and safety | 173 |
| Photosensitizer | Induction of ROS generation under UV irradiation | Attacking cell membranes, facilitating the entry of antitumor drugs into cells | Further research is needed to verify the efficacy | 174 |
| Drug carrier | Targeted delivery of anticancer drugs | Improved targeting and therapeutic efficacy of drugs | Development of various metal oxide nanoparticles | 175 |
| Biosensor | Used as a biosensor | Provides new strategies for treating hematological tumors | Good antitumor effects were observed in vitro cell experiments | 176 |
| Cell cycle arrest | Preventing cells from entering mitosis | Inhibition of tumor cell proliferation | More large-scale randomized controlled trials are needed | 177 |
| Induction of oxidative stress | Generation of excessive ROS | Leading to the apoptosis of tumor cells | Studying the cytotoxicity of ZnO NPs | 178 |
| Regulation of protein and gene expression | Activation of Caspase, influence on MT1 gene expression | Exerting tumor suppressor activity | Studying the synthesis methods of ZnO NPs | 179 |
| Regulation of Zn²⁺ homeostasis | Dissolution producing Zn²⁺, affecting intracellular homeostasis | Leading to mitochondrial dysfunction and apoptosis | Studying the biocompatibility of ZnO NPs | 180 |
| Promotion of mitophagy | Activation of PINK1/Parkin-mediated mitophagy | Inducing cell autophagy | Studying the clinical application of ZnO NPs | 83 |
| Regulation of mitochondrial membrane potential | Decreasing MMP, leading to a decline in ATP levels | Mitochondrial dysfunction | Studying the cytotoxicity of ZnO NPs | 181 |